Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1072) clinical trials

We are currently looking for study participants 50 years old and up who have been diagnosed with Type II Diabetes.

Phase

A research study is evaluating an investigational medication for patients with type 2 diabetes that is not well controlled. This research study may be an option if you: Are 40 years of age or older Have been diagnosed with type 2 diabetes Have an HbA1c of 7.0-11% Do not have ...

Phase N/A

Type 2 diabetes is a growing health concern worldwide with an estimated 194 million adults diagnosed across the country. Help advance diabetic research by participating in a new study at Clinical Trials of Texas, Inc. This new study is testing an investigational injectable medication for those with type 2 diabetes. ...

Phase

A 26-week open-label study assessing the efficacy and safety of the insulin glargine/lixisenatide fixed ratio combination in adults with Type 2 Diabetes inadequately controlled on GLP-1 receptor agonist and metformin ± pioglitazone.

Phase

A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy SONAR: Study of Diabetic Nephropathy with Atrasentan.

Phase

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events.

Phase

A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo® compared to commercially available basal insulins for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus.

Phase